Title (croatian) PSORIJAZA
Title (english) PSORIASIS
Author Marija Kaštelan
Author's institution University of Rijeka Faculty of Medicine (Department of Dermatovenerology)
Scientific / art field, discipline and subdiscipline BIOMEDICINE AND HEALTHCARE Clinical Medical Sciences Dermatovenerology
Abstract (croatian) Psorijaza je kronično-recidivirajuća upalna bolest kože od koje u svijetu boluje 2 – 3%, a u Hrvatskoj oko 1,6%
pučanstva. Danas se psorijaza smatra upalnom multisustavnom bolesti koja uz kožu može zahvatiti i brojne druge
organske sustave u obliku razvoja komorbiditeta poput hipertenzije, dijabetesa, kardiovaskularnih bolesti, upalnih
bolesti crijeva i oka te psihosocijalnih komorbiditeta. Najčešći komorbiditet u psorijazi jest psorijatični artritis koji
zahvaća 30 – 40% bolesnika, iako točni epidemiološki podatci nisu poznati. Nova paradigma poimanja psorijaze i
psorijatičnog artritisa danas govori da je riječ o psorijatičnoj bolesti koja ima kožne i/ili muskuloskeletne manifesta cije.
Suvremeno liječenje psorijaze temeljeno na dokazima uključuje kliničko iskustvo, znanstvene dokaze, ali i želje
pacijenata prilikom odabira odgovarajuće terapije. Biološka terapija u liječenju psorijaze znatan je napredak u
odnosu prema klasičnoj terapiji psorijaze zbog visoke učinkovitosti i dobre sigurnosti novih lijekova.
Abstract (english) Psoriasis is a chronic infl ammatory skin disease aff ecting about 2-3% of the world population, and around 1.6%
of the population in Croatia. Nowadays, psoriasis is considered to be a multisystemic infl ammatory disease with a
variety of comorbidities such as hypertension, diabetes, cardiovascular diseases, infl ammatory bowel and eye diseases,
and psychosocial comorbidities. Th e most common comorbidity in psoriasis is psoriatic arthritis, aff ecting about
30-40% of patients, although accurate epidemiological data are not available. Nowadays, the new paradigm of psoriasis
and psoriatic arthritis uses the term psoriatic disease with skin and/or musculoskeletal manifestations. Contemporary
treatment of psoriasis relies on evidence-based medicine including clinical experience, scientifi c evidence, but also
patients’ desires when choosing the appropriate therapy. Biological therapy in the treatment of psoriasis represents a
signifi cant progress compared to classical psoriasis therapy, due to the high effi cacy and safety of new drugs.
Keywords (croatian)
Psorijaza – dijagnoza, genetika, imunologija, liječenje
Komorbiditet
Psorijatični artritis
Biološko liječenje
Keywords (english)
Psoriasis – diagnosis, genetics, immunology, therapy
Comorbidity
Arthritis, psoriatic
Biological therapy
Language croatian
Publication type Professional paper - Review paper
Publication status Published
Peer review Peer review
Publication version Published version
Journal title Reumatizam
Numbering vol. 64, no. suppl. 1, pp. 31-36
p-ISSN 0374-1338
URN:NBN urn:nbn:hr:184:732153
Publication 2017-10-25
Document URL http://hrcak.srce.hr/188334
Type of resource Text
Access conditions Open access
Terms of use
Created on 2017-11-02 18:28:43